Clinical Trial Update: A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease [Phase 2, Phase 3]

View source ↗

Summary

Ongoing Phase 2/3 clinical trial evaluating PRX-102 in children and adolescents with Fabry disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• PRX-102

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Fabry Disease | Phase 2, Phase 3 | Status: RECRUITING